We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.38%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$56.3B
AUM Growth
-$596M
(-1%)
Cap. Flow
-$1.62B
Cap. Flow
% of AUM
-2.89%
Top 10 Holdings %
Top 10 Hldgs %
32.29%
Holding
1,743
New
37
Increased
427
Reduced
443
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$304M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$156M |
| 3 |
Monolithic Power Systems
MPWR
|
+$134M |
| 4 |
LyondellBasell Industries
LYB
|
+$128M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$374M |
| 2 |
Microsoft
MSFT
|
+$253M |
| 3 |
Apple
AAPL
|
+$200M |
| 4 |
Broadcom
AVGO
|
+$198M |
| 5 |
Meta Platforms (Facebook)
META
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.94% |
| 2 | Financials | 13.84% |
| 3 | Healthcare | 12.35% |
| 4 | Consumer Discretionary | 10.61% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Aura Biosciences
AURA
$721M
| $3.21M | 0.01% |
390,695
+118,000
| +43% | +$1.11M |
|
777
Ginkgo Bioworks
DNA
$499M
| $3.21M | 0.01% |
326,441
| – | – |
|
778
Autoliv
ALV
$9.1B
| $3.19M | 0.01% |
34,032
-20,612
| -38% | -$1.98M |
|
|
SF
779
Stifel
SF
$12.6B
| $3.19M | 0.01% |
45,084
| – | – |
|
780
Tetra Tech
TTEK
$8.93B
| $3.17M | 0.01% |
79,495
| – | – |
|
781
Apogee Therapeutics
APGE
$10.1B
| $3.16M | 0.01% |
69,750
| – | – |
|
782
Q2 Holdings
QTWO
$3.84B
| $3.14M | 0.01% |
31,213
+1,845
| +6% | +$175K |
|
783
IonQ
IONQ
$12.1B
| $3.12M | 0.01% |
74,626
| – | – |
|
|
WBA
784
DELISTED
Walgreens Boots Alliance
WBA
| $3.12M | 0.01% |
334,030
+24,427
| +8% | +$227K |
|
785
InterDigital
IDCC
$6.72B
| $3.11M | 0.01% |
16,054
+4,090
| +34% | +$715K |
|
|
SGI
786
Somnigroup International
SGI
$14.3B
| $3.1M | 0.01% |
54,596
+4,067
| +8% | +$217K |
|
787
Ryman Hospitality Properties
RHP
$8.62B
| $3.09M | 0.01% |
29,619
-24,882
| -46% | -$2.77M |
|
788
Kyndryl
KD
$3.06B
| $3.09M | 0.01% |
89,200
| – | – |
|
789
Lumen
LUMN
$6.34B
| $3.08M | 0.01% |
+580,421
| New | +$4M |
|
790
EastGroup Properties
EGP
$11.2B
| $3.07M | 0.01% |
19,145
+2,715
| +17% | +$469K |
|
791
PVH
PVH
$3.99B
| $3.06M | 0.01% |
28,893
| – | – |
|
792
Cognizant
CTSH
$26.4B
| $3.03M | 0.01% |
39,452
+2,240
| +6% | +$175K |
|
793
Henry Schein
HSIC
$9.76B
| $3M | 0.01% |
43,395
| – | – |
|
794
Jazz Pharmaceuticals
JAZZ
$16.2B
| $3M | 0.01% |
24,364
-1,883
| -7% | -$222K |
|
795
Western Alliance Bancorporation
WAL
$8.91B
| $2.99M | 0.01% |
35,790
| – | – |
|
796
Cirrus Logic
CRUS
$6.73B
| $2.99M | 0.01% |
30,024
+760
| +3% | +$83.5K |
|
|
GTLS
797
DELISTED
Chart Industries
GTLS
| $2.98M | 0.01% |
15,601
+1,160
| +8% | +$186K |
|
798
Charles River Laboratories
CRL
$11.4B
| $2.98M | 0.01% |
16,122
| – | – |
|
799
Ollie's Bargain Outlet
OLLI
$4.3B
| $2.97M | 0.01% |
27,103
| – | – |
|
800
HF Sinclair
DINO
$16.3B
| $2.95M | 0.01% |
84,185
+25,636
| +44% | +$1.05M |
|
Similar funds
SCP
Ensign Peak Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Ensign Peak Advisors held 1,743 positions worth $56.3B, down 1% from $56.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 4.1%. Ensign Peak Advisors opened 37 new positions and exited 34, leaving the 1,743-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
- Ensign Peak Advisors's largest Q4 2024 buy was State Street SPDR S&P 500 ETF Trust: 515,457 shares worth $302M.
- Ensign Peak Advisors added most to iShares Core S&P 500 ETF in Q4 2024, an estimated $156M increase.
- Ensign Peak Advisors's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $374M.
- Ensign Peak Advisors fully exited NewAmsterdam Pharma in Q4 2024, selling an estimated $4.08M.
- Ensign Peak Advisors's ten largest holdings make up 32% of its $56.3B portfolio in Q4 2024.
- Ensign Peak Advisors opened 37 new positions and closed 34 in Q4 2024.
- Ensign Peak Advisors's portfolio value fell 1% quarter-over-quarter to $56.3B.
Based on Ensign Peak Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.